secwatch.observer — SEC 8-K summary
======================================

Issuer:     MIRA PHARMACEUTICALS, INC. (MIRA)
CIK:        0001904286
Form:       8-K
Filed at:   2024-09-12T23:59:59+00:00
Accession:  0001493152-24-036057
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

MIRA Pharmaceuticals announces 2024 annual meeting results; all proposals approved
--------------------------------------------------------------------------------

- All five director nominees elected; each received over 6.6M votes (70.4% of votes cast).
- Ratification of Cherry Bekaert LLP as auditor for FY2024 approved with 9.4M votes for (99.9%).
- Amendment to 2022 Omnibus Incentive Plan to increase available shares approved with 6.57M votes for (84.6% of votes cast).
- Adjournment proposal withdrawn after sufficient votes obtained for proposals 1 and 3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1904286/000149315224036057/0001493152-24-036057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1904286/000149315224036057/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-036057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer